Bionomics Limited (BNOX)
0.2531
+0.0110 (4.59%)
Inactive · Last trade price on Dec 23, 2024
Bionomics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Operating Revenue | - | - | - | 0.26 | - | 0.05 |
Other Revenue | - | - | - | 5.79 | 0.93 | 2.95 |
| - | - | - | 6.06 | 0.93 | 2.99 | |
Revenue Growth (YoY) | - | - | - | 552.46% | -68.98% | -59.37% |
Cost of Revenue | - | - | - | 16 | 5.76 | 5.83 |
Gross Profit | - | - | - | -9.94 | -4.83 | -2.84 |
Selling, General & Admin | 7.76 | 8.47 | 8.91 | 7.66 | 5.65 | 4.85 |
Research & Development | 8.14 | 9.32 | 12.65 | - | - | - |
Other Operating Expenses | - | - | - | -0.01 | -0.2 | -0.2 |
Operating Expenses | 15.9 | 17.8 | 21.56 | 7.65 | 5.44 | 4.65 |
Operating Income | -15.9 | -17.8 | -21.56 | -17.6 | -10.28 | -7.49 |
Interest Expense | - | - | - | -0.03 | -1.43 | -1.82 |
Interest & Investment Income | 0.17 | 0.22 | 0.32 | 0.01 | 0.01 | 0.06 |
Currency Exchange Gain (Loss) | -0.49 | -0.21 | 0.31 | 0.36 | 1.08 | -0.62 |
Other Non Operating Income (Expenses) | 3 | - | - | -3.75 | -1.63 | -1.46 |
EBT Excluding Unusual Items | -13.22 | -17.79 | -20.93 | -21.01 | -12.25 | -11.33 |
Gain (Loss) on Sale of Investments | 2.21 | 2.21 | -0.59 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | -0 | -0.02 | 0.17 |
Other Unusual Items | - | - | - | -0.94 | 3.38 | 5.13 |
Pretax Income | -11.01 | -15.58 | -21.52 | -21.95 | -8.88 | -6.03 |
Income Tax Expense | -0.18 | -0.09 | -0.14 | -0.19 | -0.19 | -0.21 |
Earnings From Continuing Operations | -10.82 | -15.49 | -21.38 | -21.76 | -8.7 | -5.82 |
Earnings From Discontinued Operations | - | - | - | - | - | -1.3 |
Net Income | -10.82 | -15.49 | -21.38 | -21.76 | -8.7 | -7.12 |
Net Income to Common | -10.82 | -15.49 | -21.38 | -21.76 | -8.7 | -7.12 |
Shares Outstanding (Basic) | 12 | 10 | 8 | 8 | 4 | 3 |
Shares Outstanding (Diluted) | 12 | 10 | 8 | 8 | 4 | 3 |
Shares Change (YoY) | 41.23% | 22.39% | 8.53% | 73.52% | 43.14% | 4.52% |
EPS (Basic) | -0.92 | -1.55 | -2.62 | -2.89 | -2.01 | -2.35 |
EPS (Diluted) | -0.92 | -1.55 | -2.62 | -3.60 | -2.01 | -2.35 |
Free Cash Flow | -14.68 | -14.68 | -14.64 | -21.76 | -7.54 | -3.91 |
Free Cash Flow Per Share | -1.24 | -1.47 | -1.79 | -2.89 | -1.74 | -1.29 |
Gross Margin | - | - | - | -164.21% | - | -94.76% |
Operating Margin | - | - | - | -290.62% | -1107.29% | -250.19% |
Profit Margin | - | - | - | -359.34% | -937.11% | -237.89% |
Free Cash Flow Margin | - | - | - | -359.30% | -812.46% | -130.70% |
EBITDA | -15.45 | -17.35 | -21.23 | -16.67 | -9.34 | -6.07 |
EBITDA Margin | - | - | - | -275.36% | - | -202.73% |
D&A For EBITDA | 0.45 | 0.45 | 0.33 | 0.92 | 0.94 | 1.42 |
EBIT | -15.9 | -17.8 | -21.56 | -17.6 | -10.28 | -7.49 |
EBIT Margin | - | - | - | -290.62% | - | -250.19% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.